NEXGEL (NASDAQ: NXGL) reported Q2 EPS of ($0.09), $0.04 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.88 million versus the consensus estimate of $3.08 million.

For earnings history and earnings-related data on NEXGEL (NXGL) click here.